Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market

Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market

Growing Prominence of Single Use Technologies and Biologics Market Driving Growth

RELEASE DATE
14-Feb-2017
REGION
North America
Research Code: 9AB9-00-6A-00-00
SKU: HC02722-NA-MR_19397
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC02722-NA-MR_19397

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020.

The pharma E&L testing market is expected to expand at a compound annual growth rate of 12.1% from 2015 to 2020, driven by the increasing adoption of single use technologies, increased demand due to stringent regulatory scrutiny, CROs evolving as development partners and increasing prominence of biologics leading to need for comprehensive E&L testing programs. With the increasing prominence of single use systems (SUS), the global E&L testing market is expected to experience a robust growth. Emerging markets such as India and China are becoming hubs for contract manufacturing for such services, as these countries are building strong local expertise in analytical laboratory testing.

The pharma industry is becoming more aware of the impact of E&L for protection of patients, leading to increased and stringent scrutiny by regulatory agencies. Bio/Pharma companies are increasingly outsourcing these services to reduce the burden on internal staff and also expedite the time to market for drugs.

Table of Contents

Key Findings

Scope and Segmentation

Overview—Pharma Extractables and Leachables

Packaging Concerns in Drug Products

Designing Extractables and Leachables Tests

Revenue Forecast

Revenue Forecast Discussion

Overall Trends in Pharma Extractables and Leachables

Trends in Pharma Extractables and Leachables—E&L Testing for SUS

Trends in Pharma Extractables and Leachables—E&L Testing for SUS (continued)

Regulatory Scenario in Pharma Extractables and Leachables Testing Market

Overview of Pharma Extractables and Leachables Outsourcing

Special Considerations Required for Large Molecules in Pharma E&L Testing

Regional Trends in Pharma Extractables and Leachables

Advances in Extractables and Leachables Technology

Customer Analysis

Growth Opportunities for Extractables and Leachables Market

Competitive Analysis—Selected Key Market Participants Intertek

Competitive Analysis—Selected Key Market Participants Smithers Rapra

Competitive Analysis—Selected Key Market Participants Toxikon

Pharma Extractables and Leachables—Indian Market Scenario

Indian Competitors in the Pharma Extractables and Leachables Market

Indian Competitors in the Pharma Extractables and Leachables Market (continued)

The Last Word

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is expected to expand at a compound annual growth rate of 12.1% from 2015 to 2020, driven by the increasing adoption of single use technologies, increased demand due to stringent regulatory scrutiny, CROs evolving as development partners and increasing prominence of biologics leading to need for comprehensive E&L testing programs. With the increasing prominence of single use systems (SUS), the global E&L testing market is expected to experience a robust growth. Emerging markets such as India and China are becoming hubs for contract manufacturing for such services, as these countries are building strong local expertise in analytical laboratory testing. The pharma industry is becoming more aware of the impact of E&L for protection of patients, leading to increased and stringent scrutiny by regulatory agencies. Bio/Pharma companies are increasingly outsourcing these services to reduce the burden on internal staff and also expedite the time to market for drugs.
More Information
No Index No
Podcast No
Author Shweta Pankaj
Industries Healthcare
WIP Number 9AB9-00-6A-00-00
Is Prebook No